Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Pheast Therapeutics, Inc.

Pheast Therapeutics, Inc.

Stage unknownRedwood City, CApheast.comOther Technology
Facts
Year of incorporation
2020sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
2 rounds
  1. Oct 7, 2025
    Form D equity offering · $24.6M (form d sold) · 7 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Pheast Therapeutics, Inc. filed Form D: $24,588,083 sold of $39,999,993, Other Technology”
  2. Jan 31, 2022
    Form D equity offering · $75.3M (form d sold) · 7 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Pheast Therapeutics, Inc. filed Form D/A: $75,250,000 sold of $75,250,000, Other Technology”
Investors on record
2 edges
People
3 officers, 4 directors
Timeline
2
  1. Oct 16, 2025
    Pheast Therapeutics, Inc. filed Form D: $24,588,083 sold of $39,999,993, Other Technology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Apr 10, 2025
    Pheast Therapeutics, Inc. filed Form D/A: $75,250,000 sold of $75,250,000, Other Technology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
34 observations
Every observation on this company